reference/18181968

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18181968

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial
endingPage	3376
issn	1078-0432 1557-3265
issueIdentifier	15
pageRange	3372-3376
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3372
bibliographicCitation	Casak SJ, Fashoyin-Aje I, Lemery SJ, Zhang L, Jin R, Li H, Zhao L, Zhao H, Zhang H, Chen H, He K, Dougherty M, Novak R, Kennett S, Khasar S, Helms W, Keegan P, Pazdur R. FDA Approval Summary: Ramucirumab for Gastric Cancer. Clin Cancer Res. 2015 Aug 01;21(15):3372–6. doi: 10.1158/1078-0432.ccr-15-0600. PMID: 26048277.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_047b93b7884d1acf853b11f1e2ee4aac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06133f6702ed6a8e9ca7d21673b5b221 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd692f85100dd0b3ebf86859be730fc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bd039bc98aa52066af1f5155310a444 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2099642ccadc286263e3629bfb747c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2670f42c2b172f2d8821bf8a4673ecef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_072e2798172bad118f144fd230c7b725 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d5d760d4db352b85094536aadb8c8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8de5b8f87ac9b1922378c780f3e9c5a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81ca8e76b13b3cd9ebb34be4d7a7c190 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f69f9de6ea577c4050b7a2fc12823bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e45edcdaacec84ec2e1a503f5b533a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f569450be27bb48985eed0cbb74aafb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbaf8bb658745c2693017c5d8488d137 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef601ed6bade503ec22a48ae09c78d56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58da0f3b7a4dd9e0049f85b1260b1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24bf06d6d9ac4e71a4a3359da5459094 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3465a15804b0b59724bf65ce1359acf9
date	2015-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/26048277 https://doi.org/10.1158/1078-0432.ccr-15-0600
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	FDA Approval Summary: Ramucirumab for Gastric Cancer
discusses	http://id.nlm.nih.gov/mesh/C562730 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0556300
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7627 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347910183

Total number of triples: 51.